Centiva Capital’s Thermo Fisher Scientific TMO Stock Holding History

Centiva Capital’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,000	Closed	-$619K	–	2393
2024 Q3	$619K	Hold	1,000	–	–	0.01%	1104
2024 Q2	$553K	Buy	+1,000	New	+$573K	0.01%	1090
2024 Q1	–	Sell	-1,000	Closed	-$531K	–	2254
2023 Q4	$531K	Sell	1,000 -1,000	-50%	-$484K	0.01%	932
2023 Q3	$1.01M	Buy	+2,000	New	+$1.07M	0.02%	637
2023 Q1	–	Sell	-200	Closed	-$110K	–	1843
2022 Q4	$110K	Hold	200	–	–	﹤0.01%	1175
2022 Q3	$101K	Hold	200	–	–	﹤0.01%	1291
2022 Q2	$109K	Buy	+200	New	+$110K	﹤0.01%	1410
2021 Q4	–	Sell	-200	Closed	-$114K	–	1543
2021 Q3	$114K	Buy	+200	New	+$110K	0.01%	1023
2020 Q3	–	Sell	-100	Closed	-$36K	–	875
2020 Q2	$36K	Hold	100	–	–	﹤0.01%	622
2020 Q1	$28K	Buy	+100	New	+$31.5K	﹤0.01%	556

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Centiva Capital's TMO Position: Q3 2025 in Review

Centiva Capital sold out of Thermo Fisher Scientific (TMO) in Q3 2025, closing a stake of 14,505 shares — an estimated $5.88M sold.

Centiva Capital first reported a position in TMO in Q4 2019 and held it in 19 quarters. The position peaked at $13.5M in Q2 2024. 2,509 funds tracked by Wall St. Rank hold TMO as of Q3 2025.

Centiva Capital reported no remaining Thermo Fisher Scientific position as of Q3 2025 after selling out during the quarter.
Centiva Capital sold 14,505 Thermo Fisher Scientific shares in Q3 2025, an estimated $5.88M.
Centiva Capital first reported a position in Thermo Fisher Scientific in Q4 2019 and held it in 19 quarters.
Centiva Capital's Thermo Fisher Scientific position peaked at $13.5M in Q2 2024.
2,509 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.

Based on Centiva Capital's 13F filing for Q3 2025, filed 14 Nov 2025.